Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Abeona Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 6 insiders, $981.0K in total
- Insiders trading
- 6
- Net value
- −$981.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Abeona Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Alvino Mark | Director | 62,065 | Sep 1, 2026 | 7 |
| Vazzano Joseph Walter | Chief Financial Officer | 492,079 | Jul 22, 2026 | 7 |
| Seshadri Vishwas | Chief Executive Officer | 1,306,108 | Jul 9, 2026 | 8 |
| O'Malley Brendan M. | SVP, Chief Legal Officer | 427,953 | Jul 9, 2026 | 5 |
| Vasanthavada Madhav | Chief Commercial Officer | 290,623 | Jul 9, 2026 | 5 |
| Alland Leila | Director | 162,614 | Jul 2, 2026 | 3 |
| Silverstein Christine Berni | Director | 119,562 | Jun 15, 2026 | 3 |
| Crombez Eric | Director | 37,313 | May 15, 2026 | 3 |
| Goldan Keith A. | Director | 32,751 | Apr 7, 2026 | 1 |
| Wuchterl Donald A. | Director | 167,935 | Feb 2, 2026 | 2 |
| Amoroso Michael | Director | 217,779 | Jan 27, 2026 | 1 |
| Charles Faith L. | Director | 176,407 | Jan 27, 2026 | 1 |
| Zeiher Bernhardt G | Director | 84,458 | Jan 27, 2026 | 1 |
| Atchinson Robert | 10% Owner | – | May 8, 2024 | 0 |
| Gross Phillip | 10% Owner | – | May 8, 2024 | 0 |
| Adage Capital Management, L.P. | 10% Owner | – | May 8, 2024 | 0 |
| Wider Todd | Director | 16,907 | Sep 28, 2022 | 0 |
| Mann Paul Elliot | Director | 16,907 | Sep 28, 2022 | 0 |
| Carr Edward | Chief Financial Officer | 400,169 | Oct 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 (view filing) | Jan 29 | 2 days | Alvino MarkDirector | SSale | −4.00K | $5.38 | −$21.5K | −5.9%64.3K after | |
| Jan 21, 2025 (view filing) | Jan 21 | Same day | Alvino MarkDirector | SSale | −4.00K | $5.10 | −$20.4K | −5.5%68.3K after | |
| Jun 20, 2024 (view filing) | Jun 18 | 2 days | Alvino MarkDirector | SSale | −25.9K | $4.51 | −$116.8K | −41.2%36.9K after | |
| Jun 20, 2024 (view filing) | Jun 18 | 2 days | Silverstein Christine BerniDirector | SSale | −25.8K | $4.51 | −$116.5K | −29.4%62.1K after | |
| May 20, 2024 (view filing) | May 16 | 4 days | Alland LeilaDirector | PPurchase | +11.0K | $4.71 | +$51.8K | +15.3%82.9K after | |
| May 8, 2024 (view filing)4:15 PM ET | May 7 | 1 day | Atchinson Robert and 2 others10% Owner | PPurchase | +2.95M | $4.07 | +$12.0M | –2.95M after | Derivative |
| Apr 29, 2024 (view filing) | Apr 25 | 4 days | Seshadri VishwasChief Executive Officer | PPurchase | +10.0K | $3.20 | +$32.0K | +1.9%538.3K after | |
| Apr 29, 2024 (view filing) | Apr 26 | 3 days | Charles Faith L.Director | PPurchase | +7.55K | $3.28 | +$24.8K | +10.7%78.3K after | |
| Apr 26, 2024 (view filing) | Apr 25 | 1 day | O'Malley Brendan M.SVP, General Counsel | PPurchase | +8.60K | $3.24 | +$27.9K | +4.8%188.7K after | |
| Apr 26, 2024 (view filing) | Apr 25 | 1 day | Vazzano Joseph WalterChief Financial Officer | PPurchase | +5.61K | $3.14 | +$17.6K | +2.5%233.9K after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Seshadri VishwasChief Executive Officer | PPurchase | +20.0K | $4.39 | +$87.8K | +3.9%528.3K after | |
| Jan 22, 2024 (view filing) | Jan 17 | 5 daysLate | Alvino MarkDirector | SSale | −7.08K | $5.11 | −$36.2K | −10.1%62.8K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Silverstein Christine BerniDirector | SSale | −6.33K | $3.91 | −$24.8K | −6.7%87.9K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Charles Faith L.Director | SSale | −8.33K | $4.91 | −$40.9K | −10.5%70.8K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Alvino MarkDirector | SSale | −6.32K | $3.91 | −$24.7K | −8.3%69.9K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Amoroso MichaelDirector | SSale | −5.51K | $3.91 | −$21.5K | −4.8%109.0K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Alland LeilaDirector | SSale | −7.25K | $3.90 | −$28.3K | −9.2%71.9K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Seshadri VishwasChief Executive Officer | PPurchase | +20.0K | $4.07 | +$81.4K | +4.0%521.7K after | |
| Sep 22, 2023 (view filing) | Sep 20 | 2 days | Amoroso MichaelDirector | SSale | −327 | $3.90 | −$1.28K | −0.3%114.5K after | |
| Sep 20, 2023 (view filing) | Sep 19 | 1 day | Vazzano Joseph WalterChief Financial Officer | PPurchase | +3.00K | $3.82 | +$11.5K | +1.3%238.2K after | 2 lots |
| Sep 19, 2023 (view filing) | Sep 18 | 1 day | O'Malley Brendan M.SVP, General Counsel | PPurchase | +3.00K | $3.80 | +$11.4K | +1.6%187.4K after | |
| Jun 21, 2023 (view filing) | Jun 20 | 1 day | Amoroso MichaelDirector | SSale | −338 | $4.45 | −$1.50K | −0.3%114.8K after | |
| May 5, 2023 (view filing) | Apr 25 | 10 daysLate | Alvino MarkDirector | SSale | −887 | $3.25 | −$2.88K | −4.8%17.5K after | |
| Mar 21, 2023 (view filing) | Mar 20 | 1 day | Amoroso MichaelDirector | SSale | −268 | $2.33 | −$624.44 | −0.5%56.4K after | |
| Mar 3, 2023 (view filing) | Mar 3 | Same day | Amoroso MichaelDirector | SSale | −1.00K | $2.38 | −$2.38K | −1.7%56.7K after | |
| Dec 12, 2022 (view filing) | Dec 9 | 3 days | O'Malley Brendan M.SVP, General Counsel | PPurchase | +5.87K | $3.13 | +$18.4K | +6.7%93.8K after | |
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | Vazzano Joseph WalterChief Financial Officer | PPurchase | +2.50K | $4.00 | +$10.0K | +2.7%95.3K after | |
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | O'Malley Brendan M.SVP, General Counsel | PPurchase | +7.50K | $3.99 | +$29.9K | +9.3%88.0K after | |
| Jun 17, 2022 (view filing)4:17 PM ET | Jun 15 | 2 days | Alvino MarkDirector | SSale | −20.0K | $0.1549 | −$3.10K | −42.4%27.2K after | |
| Jun 7, 2022 (view filing)4:05 PM ET | Jun 6 | 1 day | Alvino MarkDirector | SSale | −35.0K | $0.1561 | −$5.46K | −42.6%47.2K after | |
| Dec 8, 2021 (view filing) | Dec 6 | 2 days | O'Malley Brendan M.SVP, General Counsel | SSale | −8.88K | $0.57 | −$5.06K | −4.2%204.8K after | |
| Nov 5, 2021 (view filing) | Nov 5 | Same day | O'Malley Brendan M.SVP, General Counsel | SSale | −8.88K | $0.89 | −$7.90K | −4.0%213.6K after | |
| Oct 13, 2021 (view filing) | Oct 11 | 2 days | O'Malley Brendan M.SVP, General Counsel | SSale | −25.7K | $0.90 | −$23.2K | −10.4%222.5K after | |
| Oct 8, 2021 (view filing) | Oct 7 | 1 day | Wider ToddDirector | SSale | −25.0K | $0.97 | −$24.3K | −100.0%0 after | |
| Oct 8, 2021 (view filing) | Oct 5-8 | 3 daysLate | O'Malley Brendan M.SVP, General Counsel | SSale | −25.2K | $1.05 | −$26.5K | −9.2%248.2K after | 2 lots |
| Oct 8, 2021 (view filing) | Oct 8 | Same day | Carr EdwardChief Financial Officer | SSale | −29.1K | $1.05 | −$30.6K | −6.8%400.2K after | |
| Oct 4, 2021 (view filing) | Sep 30 | 4 days | Amoroso MichaelChief Executive Officer | SSale | −45.4K | $1.09 | −$49.5K | −7.0%604.6K after |